despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . pdf . .
the comments below have not been moderated.
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian. .